Mycophenolate Mofetil for Immune Thrombocytopenia (FLIGHT) | UPDATES IN MEDICINE
Mycophenolate Mofetil for Immune Thrombocytopenia (FLIGHT)
In a multicenter, open-label, randomized trial in patients with immune thrombocytopenia, 91.5% of patients who received mycophenolate mofetil plus glucocorticoids had platelet levels above 100,000 per microliter, as compared with 63.9% of patients who received glucocorticoids only. Quality-of-life measures of physical function and fatigue were worse in the mycophenolate mofetil group.
